Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Possible Ameliorating Effect of N- Acetylcysteine on Type-II Diabetes Induced Nephropathy

NCT04531163 is registered in ClinicalTrials.gov with Al-Azhar University as lead sponsor.

NCT NCT04531163
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04531163 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Possible Ameliorating Effect of N- Acetylcysteine on Type-II Diabetes Induced Nephropathy
Lead sponsor
Al-Azhar University
Phase
Phase 2/3
Overall status
Unknown status
Start date
October 1, 2019
Completion date
December 1, 2020
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, type 2, diabetic kidney disease, diabetic nephropathies